Related Experiment Video
Updated: Jun 5, 2026
Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices
Published on: October 3, 2016
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned
Roy M Gulick1, Alice K Pau2, Eric Daar3
1Weill Cornell Medicine, New York, New York (R.M.G.).
Insights
The NIH COVID-19 Treatment Guidelines Panel provided expert recommendations for managing the disease. These living guidelines have now sunsetted, with professional societies taking over future updates.
Area of Science:
- Infectious Diseases
- Public Health Policy
- Clinical Practice Guidelines
Background:
- The emergence of COVID-19 in early 2020 necessitated immediate expert clinical management guidance.
- Clinicians required up-to-date information for treating a novel pathogen with unknown effective therapies.
Purpose of the Study:
- To document the experiences of the NIH COVID-19 Treatment Guidelines Panel over four years.
- To summarize final COVID-19 treatment recommendations and identify management challenges.
- To inform future public health emergency responses.
Main Methods:
- Convening an expert panel by the National Institutes of Health (NIH) in March 2020.
- Developing and frequently updating "living" treatment guidelines for COVID-19.
- Disseminating accessible guidelines to clinicians nationwide.
Main Results:
- The NIH COVID-19 Treatment Guidelines Panel released its first guidelines in April 2020.
- The Panel's work spanned four years, adapting to evolving scientific understanding.
- Final recommendations were summarized, and challenges in COVID-19 management were highlighted.
Conclusions:
- The NIH COVID-19 Treatment Guidelines have sunsetted following the end of the public health emergency.
- Professional societies and organizations will now assume the role of updating treatment guidelines.
- Lessons learned will inform future responses to emerging infectious diseases.
Description:
In March 2020, the White House Coronavirus Task Force determined that clinicians in the United States needed expert treatment guidelines to optimally manage patients with COVID-19, a potentially life-threatening disease caused by a new pathogen for which no specific treatments were known to be effective.
Methods:
The U.S. Department of Health and Human Services requested that the National Institutes of Health (NIH) take the lead in expeditiously convening a panel of experts to create "living" guidelines that would be widely accessible and capable of frequent updating as important new information became available.
Recommendations:
The purpose of this article is to expand on the experiences of the NIH COVID-19 Treatment Guidelines Panel (the Panel) over the past 4 years, summarize the Panel's final recommendations for COVID-19, highlight some challenges and unanswered questions about COVID-19 management, and inform future responses to public health emergencies. The Panel was formed in March 2020, and the first iteration of the guidelines was released in April 2020. Now that the public health emergency has ended, the NIH COVID-19 Treatment Guidelines have sunsetted. This role will now fall to professional societies and organizations, such as the American College of Physicians, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the World Health Organization, all of which have been active in this area.
More Related Videos
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
09:30Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care